We are live on ! Find out more
KCM

Knoll Capital Management Portfolio holdings

AUM $180M
1-Year Est. Return 66.11%
This Fund
S&P 500
This Quarter Est. Return
+25.68%
1 Year Est. Return
+66.11%
3 Year Est. Return
+268.55%
5 Year Est. Return
+741%
10 Year Est. Return
+10,877.35%
AUM
$132M
AUM Growth
+$43.7M
Cap. Flow
+$21.2M
Cap. Flow %
16.09%
Top 10 Hldgs %
93.51%
Holding
19
New
4
Increased
1
Reduced
2
Closed
2

Top Buys

Rank Stock Value
1
CRBP icon
Corbus Pharmaceuticals
CRBP
+$6.79M
2
BX icon
Blackstone
BX
+$5.11M
3
DD icon
DuPont de Nemours
DD
+$4.93M
4
MO icon
Altria Group
MO
+$4.6M
5
KBA icon
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
+$2.74M

Top Sells

Rank Stock Value
1
KRYS icon
Krystal Biotech
KRYS
+$2.12M
2
EVOK
Evoke Pharma
EVOK
+$682K
3
NAGE
Niagen Bioscience
NAGE
+$154K
4
GLMD icon
Galmed Pharmaceuticals
GLMD
+$32K

Sector Composition

Rank Sector Weight
1 Healthcare 86.03%
2 Financials 4.07%
3 Consumer Staples 3.93%
4 Materials 3.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$38.6M 29.33%
749,815
– –
CRBP icon
2
Corbus Pharmaceuticals
CRBP
$170M
$34.7M 26.33%
166,196
+30,770
+23% +$6.79M
ABEO icon
3
Abeona Therapeutics
ABEO
$345M
$17.4M 13.2%
94,391
– –
KRYS icon
4
Krystal Biotech
KRYS
$9.88B
$6.91M 5.25%
209,986
-90,014
-30% -$2.12M
BX icon
5
Blackstone
BX
$104B
$5.35M 4.07%
+153,000
New +$5.11M
MO icon
6
Altria Group
MO
$122B
$5.17M 3.93%
+90,000
New +$4.6M
DD icon
7
DuPont de Nemours
DD
$18.6B
$4.8M 3.65%
+35,539
New +$4.93M
ALDX icon
8
Aldeyra Therapeutics
ALDX
$91.7M
$4.37M 3.32%
484,096
– –
KBA icon
9
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$150M
$3.06M 2.33%
+96,000
New +$2.74M
ECOR icon
10
electroCore
ECOR
$51.4M
$2.78M 2.11%
26,481
– –
AVXL icon
11
Anavex Life Sciences
AVXL
$222M
$2.21M 1.68%
724,205
– –
ENTX icon
12
Entera Bio
ENTX
$101M
$2.06M 1.56%
475,540
– –
GLMD icon
13
Galmed Pharmaceuticals
GLMD
$3.94M
$1.68M 1.28%
1,145
-22
-2% -$32K
EIGR
14
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.05M 0.8%
2,508
– –
SNGX icon
15
Soligenix
SNGX
$5.5M
$767K 0.58%
3,494
– –
MTEM
16
DELISTED
Molecular Templates, Inc.
MTEM
$662K 0.5%
7,594
– –
LPCN icon
17
Lipocine
LPCN
$17.1M
$116K 0.09%
2,941
– –
EVOK
18
DELISTED
Evoke Pharma
EVOK
– –
-1,910
Closed -$682K
NAGE
19
Niagen Bioscience
NAGE
$256M
– –
-45,019
Closed -$154K

Similar funds

MGWA
Monument Group Wealth Advisors Concord, Massachusetts $180M AUM 19.81% 1-Year Est. Return
AW
Alchemi Wealth Essex, Connecticut $180M AUM
FBC
Fairfield, Bush & Co Darien, Connecticut $180M AUM 39.51% 1-Year Est. Return
AIC
Aurora Investment Counsel Atlanta, Georgia $180M AUM 0.3% 1-Year Est. Return
AG
Amiral Gestion Paris, France $180M AUM 9.43% 1-Year Est. Return
PCA
Prospect Capital Advisors Sausalito, California $180M AUM 60.99% 1-Year Est. Return
HIC
Hamrick Investment Counsel Seattle, Washington $180M AUM
FFA
Frazier Financial Advisors Columbus, Ohio $181M AUM 11.16% 1-Year Est. Return

Knoll Capital Management's Q1 2019 Portfolio in Review

As of Q1 2019, Knoll Capital Management held 19 positions worth $132M, up 50% from $87.9M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

Knoll Capital Management deployed $21.2M of net new capital in Q1 2019, opening 4 new positions and adding to 1 existing holding. Its largest new stake was Blackstone: 153,000 shares worth $5.35M.

By sector, the portfolio is most concentrated in Healthcare at 86% of assets, down from 100% a quarter earlier, followed by Financials and Consumer Staples.

On the sell side, the largest reduction was Krystal Biotech, an estimated $2.12M trimmed.

  • Knoll Capital Management's largest Q1 2019 buy was Blackstone: 153,000 shares worth $5.35M.
  • Knoll Capital Management added most to Corbus Pharmaceuticals in Q1 2019, an estimated $6.79M increase.
  • Knoll Capital Management's biggest Q1 2019 reduction was Krystal Biotech, cutting an estimated $2.12M.
  • Knoll Capital Management fully exited Evoke Pharma in Q1 2019, selling an estimated $682K.
  • Knoll Capital Management's ten largest holdings make up 94% of its $132M portfolio in Q1 2019.
  • Knoll Capital Management opened 4 new positions and closed 2 in Q1 2019.
  • Knoll Capital Management's portfolio value rose 50% quarter-over-quarter to $132M.

Based on Knoll Capital Management's 13F filing for Q1 2019, filed 15 May 2019.